The 2022 ICC classification of MNs [4,8] acknowledges the presence of the NPM1 mutation in rare CMML cases but notes that these may not be diagnosed with de novo AML, even if the blast count is 10–19% [4]. The gene discussed is NPM1; the disease is acute myeloid leukemia.